Pacific Biosciences Of California (PACB) Depreciation & Amortization - Total (2022 - 2026)

Pacific Biosciences Of California's Depreciation & Amortization - Total history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization - Total fell 57.12% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $10.1 million (down 35.81% YoY), while the FY2025 annual figure was $13.0 million, down 5.71% from the prior year.
• Depreciation & Amortization - Total was $2.2 million for Q1 2026 at Pacific Biosciences Of California, down from $2.7 million in the prior quarter.
• In the past five years, Depreciation & Amortization - Total ranged from a high of $5.1 million in Q1 2025 to a low of $2.2 million in Q1 2026.
• Historically, Depreciation & Amortization - Total has averaged $2.9 million across 5 years, with a median of $2.8 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization - Total soared 58.36% in 2025, then slumped 57.12% in 2026.
• A 5-year view of Depreciation & Amortization - Total shows it stood at $2.5 million in 2022, then gained by 17.03% to $3.0 million in 2023, then decreased by 4.5% to $2.8 million in 2024, then retreated by 3.73% to $2.7 million in 2025, then retreated by 19.59% to $2.2 million in 2026.
• The last three Depreciation & Amortization - Total figures came in at $2.2 million (Q1 2026), $2.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.